Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
about
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malariaSafety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenEvaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01EAntibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein.Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunizedFlow Cytometry Based Detection and Isolation of Plasmodium falciparum Liver Stages In VitroEfficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialRandomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic regionAFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
P2860
Q28744170-DEDEDEB3-B45A-453C-9AD1-F3F016488031Q28744573-1907F6D2-9B32-45E1-93CC-D91D30B8BDE4Q33489512-F94D764F-2E83-47DE-BDCA-28528627C5B0Q33508797-C880813A-DB6E-4B15-B805-167DBB852ED1Q33512921-2FD3E62A-21C6-4024-B687-9FF9452AE394Q33521372-EC29466A-E157-4F9C-BD13-9FA83CD553F6Q33587443-D0E1D44F-28E3-4B71-A678-17C04D8E8CDEQ34541330-834CA6A2-7506-48A4-8A12-F823AA339892Q34546220-54B29966-0C05-4E22-B6C6-F52EBDA5FE52Q34612788-E818BE0A-FD5B-4C7A-ACDC-C97FF553DE33Q35662378-23A42B66-10CA-4942-A253-630F974642DBQ35925829-2685596F-E91A-4022-A486-193299C94B0CQ36568190-5598CDDA-018B-43B9-BB67-BBAEE7861B1CQ37144187-BB1BD9FC-B2A4-46BB-BBAB-4F2FE9A7E2C8Q37355917-35764BBD-EE74-416D-A13D-73F84EAED7E3Q37461371-0C433B4C-C37D-413E-A601-254E6E4EE523Q38599514-1B63BA44-6E0A-4737-92BA-F93FFF2D8DD8Q42126049-D5BB1D38-F821-4963-90E0-E338EF2B73F9
P2860
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evaluation of two formulations ...... d double-blind bridging trial.
@ast
Evaluation of two formulations ...... d double-blind bridging trial.
@en
type
label
Evaluation of two formulations ...... d double-blind bridging trial.
@ast
Evaluation of two formulations ...... d double-blind bridging trial.
@en
prefLabel
Evaluation of two formulations ...... d double-blind bridging trial.
@ast
Evaluation of two formulations ...... d double-blind bridging trial.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Evaluation of two formulations ...... d double-blind bridging trial.
@en
P2093
Amanda Leach
Caterina Guinovart
Conor P Cahill
Eusebio V Macete
Filip Dubovsky
Jessica Milman
Marc Lievens
Margarita M Navia
Marguerite Koutsoukos
P2860
P2888
P356
10.1186/1745-6215-8-11
P577
2007-03-26T00:00:00Z